KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Taylor Morrison Home (TMHC) Cost of Revenue (2016 - 2026)

Taylor Morrison Home has reported Cost of Revenue over the past 15 years, most recently at $89.9 million for Q1 2026.

  • For Q1 2026, Cost of Revenue fell 93.73% year-over-year to $89.9 million; the TTM value through Mar 2026 reached $7.7 billion, up 64.66%, while the annual FY2025 figure was $6.3 billion, 1270.62% up from the prior year.
  • Cost of Revenue for Q1 2026 was $89.9 million at Taylor Morrison Home, down from $5.9 billion in the prior quarter.
  • Over five years, Cost of Revenue peaked at $5.9 billion in Q4 2025 and troughed at -$3.7 billion in Q4 2023.
  • A 5-year average of $978.8 million and a median of $115.4 million in 2025 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: plummeted 163.03% in 2023 and later surged 4751.65% in 2025.
  • Year by year, Cost of Revenue stood at $5.9 billion in 2022, then plummeted by 163.03% to -$3.7 billion in 2023, then surged by 103.3% to $121.8 million in 2024, then surged by 4751.65% to $5.9 billion in 2025, then plummeted by 98.48% to $89.9 million in 2026.
  • Business Quant data shows Cost of Revenue for TMHC at $89.9 million in Q1 2026, $5.9 billion in Q4 2025, and $115.4 million in Q3 2025.